Table 1.
Baseline Characteristics of the 3 Groups of Patients With CHD
| ASD (n = 15) | VSD (n = 24) | PDA (n = 16) | P | |
|---|---|---|---|---|
| Age, y | 32.20 ± 6.32 | 26.58 ± 9.61a | 23.75 ± 7.47b | 0.020 |
| Male/ female ratio | 0/15 | 8/16 | 4/12 | 0.093 |
| Weight, kg | 50.17 ± 10.26 | 52.78 ± 12.85 | 48.81 ± 11.71 | 0.565 |
| WHO functional class (mean ± SD) | 2.3 ± 0.5 | 2.3 ± 0.4 | 2.3 ± 0.6 | 0.994 |
| II, n (%) | 11 (73.3) | 18 (75.00) | 13 (81.3) | |
| III, n (%) | 4 (26.7) | 6 (25.00) | 2 (12.5) | |
| IV, n (%) | 0 (0) | 0(0) | 1 (6.2) | |
| Shunt patency, n (%) | ||||
| Open | 14 (93.3) | 22 (91. 7) | 15 (93.7) | 1.000 |
| Closed | 1 (6.7) | 2 (8.3) | 1 (6.3) | |
| Concomitant medication, n (%) | ||||
| Diuretic | 13 (86.7) | 17 (70.8) | 14 (87.5) | 0.432 |
| Digoxin | 10 (66.7) | 16 (66.7) | 12 (75.0) | 0.869 |
| Warfarin | 7 (46.7) | 5 (20.8) | 7 (43.8) | 0.168 |
Abbreviations: ASD, atrial septal defects; CHD, congenital heart disease; PDA, patent ductus arteriosus; SD, standard deviation; VSD, ventricular septal defects; WHO, World Health Organization.
Significant compared with ASD group.
a
P = 0.043.
b
P = 0.006.